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AbsTrACT
background Use of routinely collected patient data 
for research and service planning is an explicit policy 
of the UK National Health Service and UK government. 
Much clinical information is recorded in free- text letters, 
reports and notes. These text data are generally lost to 
research, due to the increased privacy risk compared 
with structured data. We conducted a citizens’ jury which 
asked members of the public whether their medical free- 
text data should be shared for research for public benefit, 
to inform an ethical policy.
Methods Eighteen citizens took part over 3 days. 
Jurors heard a range of expert presentations as well as 
arguments for and against sharing free text, and then 
questioned presenters and deliberated together. They 
answered a questionnaire on whether and how free 
text should be shared for research, gave reasons for and 
against sharing and suggestions for alleviating their 
concerns.
results Jurors were in favour of sharing medical data 
and agreed this would benefit health research, but were 
more cautious about sharing free- text than structured 
data. They preferred processing of free text where a 
computer extracted information at scale. Their concerns 
were lack of transparency in uses of data, and privacy 
risks. They suggested keeping patients informed about 
uses of their data, and giving clear pathways to opt out 
of data sharing.
Conclusions Informed citizens suggested a transparent 
culture of research for the public benefit, and continuous 
improvement of technology to protect patient privacy, to 
mitigate their concerns regarding privacy risks of using 
patient text data.
InTroduCTIon
The use of medical data for secondary purposes 
such as health research, audit, care quality improve-
ment and service planning is well established in 
the UK, and technological innovation in analyt-
ical methods for new discoveries using these data 
resources is developing quickly.1–3 Data scientists 
have developed, and are improving, many ways 
to extract and process information from medical 
records. This continues to lead to an exciting range 
of health- related discoveries, improving popula-
tion health and saving lives across diverse areas 
such as improving health outcomes for people with 
learning difficulties, drug safety in children with 
chronic conditions and how to personalise treat-
ments for cancer.4
Nevertheless, as the development of analytic 
technologies accelerates, this raises increasingly 
urgent questions about the suitability of the existing 
ethical and governance landscape.5 Inherent to 
ethics discussions is the need for greater under-
standing of public awareness, opinion and accep-
tance of this work, an area where the evidence often 
lags behind.6 7 One area where this is especially true 
is in the use of free text from medical records.
What are the differences between structured and 
unstructured (free-text) data?
Much current health data research and innovation 
uses patient data stored in electronic health records 
(EHRs). EHR data can be structured or unstruc-
tured. Structured data are organised using a code 
set of predefined clinical concepts (eg, Read codes, 
SNOMED, etc) relevant to observations, diagnoses, 
treatments and other investigations or interven-
tions. These types of data can be easily de- identified, 
formatted into databases and processed statistically 
at scale. This contrasts with unstructured medical 
data called ‘free text’, which is clinical information 
written in words, which are narrative in nature 
and not limited to predefined values or structures 
(table 1).
Why is medical free text important for research?
Much influential epidemiological research has 
been published in the UK from general practice 
(GP) medical record databases, for example, on 
the safety of vaccines, of oral contraceptives and of 
medications taken during pregnancy.8–11 Typically, 
studies have relied on structured data, because GPs’ 
written notes and letters are not commonly avail-
able in these databases. However, this is problematic 
given that several studies have shown that clinical 
information is lost when medical data in the form 
of unstructured text are not used.12–17 Part of the 
problem is that clinical information is often missing 
from structured fields. This may be due to a variety 
of reasons including clinical uncertainty, stigma, 
loss of information between secondary and primary 
care, time pressures or poor clinician training in 
the coding structure. For example, in the case of 
UK general practice, many GPs describe choosing 
a ‘summary’ code, which is a keyword representing 
the main body of the consultation (table 1).14 The 
GP may then add text under the code to capture 
complexity, evolving circumstances, uncertainty 
and severity.18 If only the coded data are available, 
all of this additional clinical and contextual infor-
mation may be lost to researchers who subsequently 
use GP patient data for research. In our previous 
research, we also found much clinical information, 
such as a new diagnosis, was incorporated into 
the record only within letters which came from 
specialist clinics in the hospital.19 However, these 
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Table 1 Examples of structured and unstructured data within 
general practice medical records
data item
Examples
structured* unstructured
Time dd/mm/yyyy
14 September 2017
Prescription start date: dd/mm/yy
‘Earlier today Mr X experienced 
chest pain’
‘Operation scheduled on 
Tuesday’.
Symptoms N242300 Neuropathic pain
1B1B.00 Cannot sleep—insomnia
‘…c/o shooting pain in upper 
right leg during the night, 
disturbing her sleep’
Diagnosis C109912 Type 2 diabetes without 
complication
‘The patient has diabetes without 
complications’
Prescription 01040200 (BNF code for codeine 
phosphate 60 mg tablets)
‘Px codeine 60 mg PO qid×7 
days’
Referral 8H4D.00 Referral to 
psychogeriatrician
Rev 4 w ?refer pyscho ger
Test 43F1.00 Rheumatoid factor 
positive
Rheumatoid factor was 42 IU/mL 
which is a positive result
*These codes represent Read codes, a UK- based, alphanumeric clinical coding 
system for general practice, and British National Formulary (BNF) codes, which 
represent the full list of medications available in the UK.
were often recorded under an administrative code such as ‘letter 
from specialist’ rather than a diagnostic code relating to the clin-
ical information they communicated.19 It has been shown that, 
when using GP data, additional information about symptoms20 
and date of diagnosis19 can be ascertained from text only.
Beyond general practice, certain types of patient data in the 
UK are generally only recorded as unstructured text. These 
include medical records produced within mental healthcare, 
where records are largely narrative in nature and very little is 
formally coded, as well as communications between doctors 
within and between hospitals, to and from primary care as well 
as between other hospital staff (eg, nursing handover notes). 
These data sources include imaging and pathology reports, 
discharge summaries and letters. Even where free text and coded 
data exist side by side, the addition of information from the text 
data to information which is coded can improve sensitivity of 
case definition in EHR research.21
The current ethics and governance landscape for free text
While there has been real progress in developing text analytic 
technology in many domains, there are challenges to developing 
such technologies for medical or health research applications, 
due to the reluctance of patient data providers to give access to 
free text. Many text analysis research groups in the UK report 
that being refused access to medical text is the main barrier 
using these data to improve health and healthcare.22 The reluc-
tance relates to concerns about patient privacy. Patient data are 
usually de- identified before being shared for research, following 
which they are usually held and analysed in a secure computing 
environment with only trusted individuals being allowed access. 
However, policy makers routinely judge that the risk of re- iden-
tifying patients from text data is too high for these data uses. 
While automated methods for stripping text of identifiers (of 
both patients and third parties) exist, they are not perfect, 
performing at 81%–99% sensitivity (recall) and 43%–99% 
precision,23 24 and consequently many data custodians refuse 
to share text outside of the clinical environment. In contrast, 
the few UK research groups that are situated within healthcare 
trusts and can access medical text which remains within the clin-
ical environment, have established good track records in terms 
of technology development,25 protecting patient privacy26 and 
generating clinical insights.27–29
What does the public think about their medical free text 
being used for research?
Two recent reviews examined studies of public views on sharing 
medical records for research.6 7 Both found that no previous 
study explicitly differentiated between text data and structured 
data within medical records. Aitken et al.7 found two studies 
in which participants indicated that they were more comfort-
able with the idea of their health data being turned into ‘figures 
for doing stats’30 and were uncomfortable with the idea of 
researchers ‘having everything in there because it is not rele-
vant’.30 31 They also found a study on public views of using social 
media data for health research which mirrored these findings, 
in which participants indicated that if written posts were aggre-
gated and used for statistics, participants were more likely to 
be agreeable to the research happening without their consent. 
Aitken 30 and Aitken et al7 also reported that across studies, 
participants regarded certain types of data as more sensitive, 
including data relating to mental health, sexual health, sexuality 
and religion. However, no research has explored in detail with 
the public the specific question of whether they feel differently 
about their structured or unstructured patient data being shared 
for research. Addressing this gap in knowledge of public opinion 
is a crucial step towards informing and influencing an ethical 
approach to access to patient data in line with the evolving 
analytical techniques evident in this space.
Why conduct deliberative research on this topic?
Deliberative research has been used widely when forging policy 
for health issues which may be controversial or for when there 
are complex ethical issues to resolve.32 Like many ethical issues, 
balancing privacy risks with the research benefits of sharing free- 
text data is a complex area with a lot of information and many 
arguments to consider. While surveys and focus groups provide 
useful information about what the public thinks on certain 
topics, they are less appropriate for gathering information on 
topics that the average member of the public might know little 
about. Public deliberation is an approach designed to capture 
in- depth and informed public perspectives on complex topics.33 
Deliberative democracy in healthcare typically aims to achieve 
public engagement, shared decision- making and patient- centred 
care.32 Additionally, deliberative methods have previously been 
used to address issues of policy in health or medical research and 
data sharing.34 35
Research has already shown general public willingness for 
medical data to be shared for research for the common good.6 
However, there is reason to believe that public may have different 
views on unstructured text data being analysed for research 
compared with structured data, as it has the capacity to tell more 
details of the patient story, provide additional contextual infor-
mation and identify third parties (eg, family members).30 31 Thus, 
it may be harder to secure public approbation, also known as a 
social license, to use medical text data for research. According to 
social licence theory, organisations can engender trust from the 
public for schemes which may initially be controversial (such as 
data sharing), by voluntarily adhering to social codes of trust-
worthy and responsible behaviour that go beyond legal or regu-
latory frameworks and by honouring additional safeguards.36 
Where the public are satisfied that the motivations of the organ-
isation are trustworthy, they grant a ‘social licence’ to operate. 
It has been hypothesised that previous patient data- sharing 
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initiatives, such as  Care. data, failed precisely because they lacked 
a social licence for their operation.37
No evidence currently exists about what public perceptions 
are of medical free text being shared, processed and analysed. 
For example, it is plausible that additional privacy safeguards 
may be desirable when using text data compared with coded 
data. We therefore sought to gather detailed evidence on this 
topic for the first time. We chose a deliberative approach for 
this study, in order to inform participants about the complex 
issues, and to give them space to reflect on the topics and give 
their opinion. We planned and undertook a citizens’ jury asking 
a group of members of the public to deliberate on whether 
medical free text should be shared for research.
METhods
The citizens’ jury method
In a citizens’ jury, a broadly representative sample of citizens 
are selected to come together for a period of days, hear expert 
evidence, deliberate together and reach reasoned conclusions 
about questions posed to them. The method was developed by 
Ned Crosby, the founder of the Jefferson Center in the USA, in 
the 1970s.38
A citizens’ jury can tell policymakers what members of the 
public think once they have become more informed about a 
policy problem.39 Juries are a form of deliberative democracy, 
based on the idea that individuals from different backgrounds 
and with no special prior knowledge or expertise can come 
together and tackle a public policy question.39–41 Deliberative 
democracy is an egalitarian approach which encourages mutual 
recognition and respect and allows public negotiation of the 
common good.39 Citizens who take part are encouraged to 
deliberate in an environment free of ‘delusion, deception, power 
and strategy’, and in which all parties have an equal right to 
be heard.42 A citizens’ jury is a particularly relevant method 
for informing public bodies making value judgements. Juries 
are increasingly used for informing health policy on ethically 
complex topics such as genetic testing,43 use of patient data,34 
screening services,44 case finding for stigmatised diseases45 and 
health service resource distribution, among others.46
Expert witnesses present information to the jury, and care is 
taken to make sure the full range of views is presented equiva-
lently. The jury discussions are assisted throughout by impartial 
facilitators.
reducing bias in the jury
To make sure this jury was conducted appropriately and to 
reduce bias, the running of the jury was contracted to Citizens’ 
Juries CIC, a UK- based social enterprise who recruited the citi-
zens and expert witnesses, and managed the project. Citizens’ 
Juries CIC worked in partnership with the Jefferson Center, 
who led the design and facilitation of the 3- day jury process. An 
external oversight committee was recruited, who reviewed all 
materials for the jury to identify potential bias, including presen-
tations, questionnaires and planned activities. The oversight 
panel members were chosen for their knowledge of the topic 
and lack of conflict of interest in any particular jury outcome, 
and was made up of the NHS England Head of Data Sharing and 
Privacy, the Head of the Office of the National Data Guardian 
and the Director of Public Engagement for Connected Health 
Cities, an umbrella organisation which unities local health data 
and technology to improve health services in cities across the 
north of England.
The jury questions, and the consequent topics for witnesses 
and deliberations, were planned and refined over the course of 
6 months by all authors. Prior to the jury, the panel reviewed the 
citizens’ jury questions and design, and much of the detailed jury 
documentation, including the jury questionnaires and the slides 
from the presentations by the expert witnesses, resulting in some 
changes to these materials.
Participant recruitment
The jury was advertised on the Indeed job website ( www. indeed. 
co. uk), on Brighton community base website (http://www. 
communitybase. org) and by word of mouth. Interested members 
were invited to apply to participate by filling in a questionnaire, 
which asked for information on gender, age range, ethnicity and 
educational attainment, as well as an Ipsos MORI survey ques-
tion from a 2016 poll of the public commissioned by the Well-
come Trust35: “How willing or unwilling would you be to allow 
your medical records to be used in a medical research study? The 
information given to researchers would not include your name, 
date of birth, address or any contact details”.
In total, 227 members of the public responded to the advert 
by filling in the online survey. Candidates were chosen from 
this pool of applicants using a sampling logic of representative-
ness, and trying to achieve matches on gender, age ethnicity 
and educational attainment with UK census data for England.47 
We also aimed to recruit a jury whose views on data sharing 
broadly reflected those in the wider population based on the 
Ipsos MORI question. Citizens’ jury members are often selected 
purely according to demographics, but occasionally on the basis 
of responses to questions on allied topics, where recruiters seek 
to bring a diverse range of voices within the jury.46 The strati-
fied sample of recruited jurors closely reflected England’s demo-
graphic mix, and the range of views expressed in the Ipsos MORI 
survey. Healthcare professionals and specialists in law and infor-
mation governance were excluded, as their specialist knowledge 
of the subject area may have resulted in other members of the 
jury deferring to them, and holding back from freely expressing 
their views.
Each juror was paid £300 for 3 days plus a £25 expense allow-
ance. Three ‘reserve jurors’ were also recruited. One participated 
until lunch on day 1 and was paid £75. The two other reserves 
became full members of the jury, after one original juror called in 
sick and another left for personal reasons early on day 1.
Expert witnesses
From the jury questions, the main information needs of the 
jury were identified, and an expert witness brief was developed 
(downloadable from http:// healtex. org/ jury/). Seven expert 
witnesses were chosen to provide relevant information about 
healthcare text analytics and research. The choice of witnesses 
was discussed extensively in the research team and the research 
team endeavoured to use local witnesses where possible, and to 
achieve diversity of demographics in the witnesses. Each witness 
answered questions posed by the jurors. They all presented 
slides which were reviewed for bias in advance by the oversight 
panel. Five expert witnesses were impartial witnesses who were 
instructed to present information to the jurors without trying to 
influence their views. These witness presentations covered:
1. Patient records: what they contain in codes and text, and 
how clinicians decide what to record, delivered by a 
clinician- researcher.
2. How free text can be de- identified by computers and how 
successful this is, delivered by a computer scientist.
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3. Five processes by which information is extracted from med-
ical free text to use for research, delivered by a health re-
searcher.
4. Ethical issues around the use of patient data and free text 
specifically, delivered by a bioethicist.
5. The law around the use of patient data, delivered by a barris-
ter also trained as a doctor.
In addition, a researcher made the case for the use of free 
text being shared for research, and a medical confidentiality 
campaigner made the case for being cautious about data sharing. 
We did not cover other data- sharing topics such as records 
linkage or commercial uses of patient data. Full documentation 
for the jury, including presentation slides, can be seen at http:// 
healtex. org/ jury/.
The jury process
The 3- day jury programme was facilitated by a representative of 
the Jefferson Center, USA.
On the first day, patients gave informed consent for partici-
pation, and listened to an introductory presentation to explain 
the citizens’ jury method. They heard expert witness 1, and then 
undertook an exercise to anonymise a health record. They then 
heard expert witnesses 2 and 3, and a third witness (witness 5) 
engaged the jury in a session of question and answer with these 
two witnesses. The balancing witness was briefed to ask chal-
lenging questions to the experts on free text de- identification 
and information extraction, to attempt to counterbalance the 
potential bias that comes from explaining about uses and value 
of free- text data; as these witnesses may have been perceived as 
favouring the case for using free- text data.
On day 2, the jury deliberated further on the anonymisation 
and processing of free text, and then listened to presentations 4 
and 5 (see above). In the afternoon, they heard the two witnesses 
who made the case for and against the sharing of free- text data.
On day 3, jurors worked together extensively in groups, and 
were encouraged to deliberate, listening and responding to the 
thoughts expressed by others. They deliberated on the jury ques-
tions, and prioritised their reasons for answering their questions 
in a certain way. They voted on the jury questions individually 
and anonymously. Jurors were not instructed on whether they 
should think about what is best for everyone or focus on what is 
best for themselves. They deliberated on how to generalise from 
the case example used in the questions, and worked together 
with facilitators to create a jury report. They filled in an end- of- 
jury questionnaire.
Jury questionnaire
The questionnaire was developed specifically for this jury with 
the contribution of all authors over a 6- month period. The ques-
tions were tested with 10 members of the public in a half- day 
public workshop and feedback was received. There were five 
sections to the main jury questionnaire. See online supplemen-
tary appendix 1 for the jury questionnaire in full, and http:// 
healtex. org/ jury/ for full jury documentation.
Section 1: Tom scenario
The jury were presented with a case scenario about a man aged 
43 years who registered newly with a GP practice after living 
abroad. Tom’s GP finds he has symptoms of diabetes and records 
information about this in the patient record. Later on, Tom has 
mental health symptoms and is seen in the local mental health-
care service. The local university wants access to both types of 
patient records for research purposes.
The jury were asked whether the GP practice and the mental 
health trust should release (a) the coded data about diabetes; 
(b) the free- text data about diabetes and (c) the free- text data 
about mental health. They were asked to give their reasons for 
any difference in response to these three questions. The response 
scale was: (a) ‘yes’, (b) only if Tom and the other patients can 
opt out, (c) only if Tom and the other patients can opt in, (d) no 
and (e) other.
Section 2: views on the method of de-identification of free text
In this section, the jury were asked three questions about how 
comfortable they felt about the de- identification of free text 
being undertaken by a person, a computer or a combination of 
a person and a computer. They responded on a 5- point Likert 
scale from comfortable to uncomfortable.
Section 3: views on methods of processing free text to extract 
information for research
In this section, the jury were asked five questions about processes 
for coding or analysing free text for research purposes. These 
included text being converted into structured data by a clini-
cian or medical student, being used to train a computer algo-
rithm to extract information from text or a computer algorithm 
extracting information from text unsupervised. It also included 
a scenario where researchers conducted a qualitative analysis on 
small bodies of medical text. Jurors responded to the scenarios 
on a 5- point Likert scale from strongly supportive to strongly 
unsupportive.
Section 4: summary question
Jurors were asked the question “You have heard reasons to 
support the process of anonymising, coding and using free- text 
data for health research, and reasons to be concerned about the 
process. Given these, to what degree do you support the use of 
free- text data from patients’ records for health research?” and 
responded on a 5- point Likert scale from strongly supportive to 
strongly unsupportive.
Section 5: reasons and suggestions
The jury were asked three questions to elicit qualitative data 
about reasons to support sharing of medical text, reasons to be 
concerned about sharing of medical text and suggestions about 
how these concerns could be overcome. Jurors deliberated on 
these three questions as a group and their responses to these 
questions were generated during a facilitated discussion and 
agreed as a group.
End-of-jury questionnaire
At the end of the jury questionnaire, the participants were asked 
the Ipsos MORI screening question once more, as well as four 
further questions: how interesting they found the jury, whether 
facilitators tried to influence them to particular conclusions, 
whether any other speakers (witnesses) tried to influence them 
to particular conclusions and whether the information they were 
given was a fair balance of information.
data analysis
Because only 18 participants took part, quantitative data anal-
ysis was restricted to descriptive statistics, including simple 
counts and percentages. All reasoning given in the final jurors’ 
report has also been presented verbatim to illustrate the jurors’ 
responses. Limited qualitative data were collected during delib-
erations of the jury, and so no formal analysis of the deliberations 
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Figure 1 Demographic make- up of jury against average for England (UK Census 2011).
Table 2 Summary of juror answers
how willing or unwilling?
recruitment 
questionnaire
End- of- jury 
questionnaire
Very willing 9 9
Fairly willing 6 9
Do not know 0 0
Fairly unwilling 2 0
Very unwilling 1 0
was carried out (as is sometimes provided in other juries carried 
out for research purposes).
rEsulTs
Participant characteristics
Eighteen people were recruited from around Brighton, UK, a 
city of around 290 000 inhabitants on the southern coast of the 
UK. Of the 18 jurors, 11 people responded to an advertisement 
placed on the Indeed jobs website, 5 to an advert on Brighton’s 
Community Base website and 1 applied through word of mouth. 
Five people were in full- time or part- time employment, six were 
self- employed, three were unemployed, two were retired and 
two self- classified as having an ‘other’ employment status. The 
sample chosen was controlled for gender, age range, ethnicity (in 
terms of white/other) and educational attainment, and matched 
closely the demographics of people in England (as recorded in 
the UK Census 2011) and the range of views expressed in the 
Ipsos MORI survey. Figure 1 shows the demographics of the 18 
people who completed the 3- day process.
Willingness of participants to share health data in general
Participants were asked to respond to the following Ipsos MORI 
survey question as part of the application to the jury and after 
the jury35: “How willing or unwilling would you be to allow your 
medical records to be used in a medical research study? The infor-
mation given to researchers would not include your name, date 
of birth, address or any contact details”. Responses are shown 
in table 2.
The figures mentioned in table 2 suggest a general movement 
towards greater willingness to allow use of medical records for 
research. However, over the 3 days, 12 out of 18 people changed 
their minds and gave a different answer to the question to the 
one they originally provided during jury recruitment, with 7 
people becoming more willing and 5 becoming less willing.
Willingness of participants to share free-text data
In response to the summary question at the end- of- jury process, 
“to what degree do you support the use of free- text data from 
patients’ records for health research?” 6 jurors responded 
‘strongly supportive’ and 12 jurors responded ‘fairly supportive’. 
No jurors gave neutral or unsupportive responses. Reasons given 
by the jurors, assumed to underpin these responses, are shown 
in box 1, although these reasons to support, or be concerned 
about, text data sharing were generated after responding to the 
jury questions.
responses to jury questionnaire
All participants responded individually to the questions relating 
to the case scenario about Tom, who had diabetes, as well as 
depressive symptoms and auditory hallucinations, and was seen 
at the GP clinic and the mental health trust. Their aggregated 
responses are shown in table 3. Some comments were also made 
on questionnaires about the need for opt- outs to be made easy 
and transparent, and the need to fully inform patients, in rela-
tion to (1A), (2B) and (3B). However, it should be noted that 
some members of the jury may not have fully understood the 
difficulties of achieving easy and fully informed opt- out.
Reasons for differences in response between question 1 
and question 2 were given by four participants. These are all 
shown in box 2. Nobody indicated that they responded differ-
ently to the free- text sharing question about diabetes (question 
2) compared with the free- text sharing question about mental 
health (question 3).
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Box 1 reasons and suggestions
The main reasons to support the process of anonymising, 
coding and using free- text data for health research:
 ► There is a large amount of free- text data in patient records, 
particularly for mental health cases. This free text can be 
richer than coded data, adding ‘flesh’ to the coded data 
within a patient record.
 ► This richer data can enable better research that could lead to 
better treatments, improve care and may save lives.
 ► There is a low risk of re- identification when processing free 
text if proper procedures are followed.
 ► An opt- out system gives a larger, more representative sample 
of the population for research than an opt- in system which 
can lead to more accurate research and better results.
 ► When millions of records need to be processed by computer 
and there may be too many for humans to process effectively, 
these processes can support better research.
The main concerns about the process of anonymising, coding 
and using free- text data for health research:
 ► If people believe their data are unsafe, they may withhold 
important information when seeing their doctor.
 ► The law requires ‘fair processing’—patients must be 
informed of the uses of their data but sometimes they are 
not.
 ► There is a lack of awareness about how patient data are 
used, or by whom and that patients can opt out.
 ► People who might otherwise be willing to share information 
may be less willing to do so if they are unable to either give 
permission or be informed and able to opt out.
 ► Data processed to remove identifiers does not always mean it 
is completely anonymous.
 ► Free- text data are sensitive and inherently more identifying 
than coded data.
 ► Computer programs are currently unable to remove 
identifiers to an acceptable level with 100% accuracy.
 ► Free- text patient data could contain information about other 
patients, judgements, offhand comments and other data 
requiring interpretation, and could be misinterpreted by 
researchers.
 ► There is a procedure in place (section 251) to ask for legal 
approval to process free- text data without requiring consent 
in specific scenarios.
 ► Despite safeguards that might be in place, IT and data 
protection systems may be at risk of being accessed by third 
parties who seek unauthorised access to records and data.
suggestions for how these concerns could be overcome:
Transparency: patients should be comprehensively informed 
at the outset about how, when and under what conditions their 
free text might be processed, anonymised, coded and analysed for 
research purposes. This should include:
 ► Information that communicates their rights (to file 
complaints, to access their own information, etc).
 ► A privacy statement.
 ► How data will be protected from breaches during processing, 
analysis and once research is completed.
 ► Whether or not and how their information will be 
anonymised.
 ► Who would access it and for what purpose; and plans for 
long- term storage or management of their data.
Researchers should communicate how decisions are made about 
Continued
Box 1 Continued
who, why and under what circumstances patients’ data and 
records are being used in language that is accessible and easy to 
understand.
Efforts could be undertaken to involve patients in various 
elements of research and ethics decision- making (such as patients 
sitting on ethics boards) so that these processes are more open and 
transparent.
Providing an option for people to access (published) research 
which uses their records or data might be useful in maintaining 
trust.
Technology: there has to be continuous improvement in the 
methods used for coding, anonymising and processing free text, as 
well as in systems for safeguarding IT systems that secure access to 
data to improve performance, data protection and public confidence.
Views on human or computer de-identification of free text
The jury heard about the processes used for de- identifying free- 
text data for research. Participants indicated they were largely 
comfortable with the idea of de- identification being conducted 
by a human or a computer but overall the combination of human 
and computer was most preferred (table 4). The particular 
concerns they raised on the topic of de- identification were that 
data processed to remove identifiers does not always mean it is 
completely anonymous; free- text data are sensitive and inher-
ently more identifying than coded data; computer programs 
are currently unable to remove identifiers to an acceptable 
level with 100% accuracy and that free- text patient data could 
contain information about other patients, judgements, offhand 
comments and other data requiring interpretation, and could be 
misinterpreted by researchers (box 1).
Views on different methods of processing free text
Participants of the jury were largely supportive of the different 
methods of processing free text for research with which they 
were presented (table 5). Jurors were most supportive of the 
cases where a computer algorithm was trained to extract the 
information needed for research.
reasons for and against sharing free text for research
Participants deliberated as a group and proposed the following 
reasons to support or be concerned about the use of medical 
free- text data for research (Box 1). They also proposed ways of 
addressing these concerns. All jury members read and agreed the 
final list of reasons and suggestions before they were added to 
the final jury report.
Perceptions of bias in the jury process
At the end- of- jury questionnaire, participants were able to indi-
cate their perception of how biased the jury process had been 
towards one verdict over another. These results are shown in 
table 6. It was particularly important that the facilitators did 
not bias the jury. In comparison, two of the witnesses, putting 
the case for and against, were specifically tasked with trying to 
convince the jury in their favour. No participants perceived that 
the facilitators tried to influence the juror conclusions, whereas 
six jurors felt that other presenters had ‘perhaps occasionally’ 
tried to influence them. Fifteen jurors felt the information was a 
fair balance and three felt that there was some bias in favour of 
sharing free text.
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Table 3 Responses to data- sharing questions from Tom scenario (see online supplementary appendix 1 for full questionnaire)
Question
Participants’ responses
(A) Yes
(b) only if Tom and 
the other patients 
can opt out
(C) only if Tom and 
the other patients 
can opt in (d) no
(1) Should Anytown health centre agree to release the coded data items about Tom and all the other 
patients in the practice with suspected or confirmed type 2 diabetes?
8 8 2 0
(2) Should Anytown health centre also agree to release the free- text data items about Tom and all the 
other patients in the practice with suspected or confirmed type 2 diabetes?
4 12 2 0
(3) Should Anytown mental health trust agree to release the free- text data items about Tom and all the 
other patients in the trust who hear voices or have hallucinations?
4 12 2 0
Box 2 reasons given for different response to free- text 
question
 ► ‘There may be more sensitive information including about 
other people in free text and some identifiers may slip 
through’.
 ► ‘Because in the first case it is coded data but free text in the 
second’.
 ► ‘Further information to Tom as to how data will be used that 
is, more people with diabetes will gain better healthcare or a 
cure may be found’.
 ► ‘Because free- text data are far more sensitive than coded 
information is and can be easily readable and leaked more 
easily’.
dIsCussIon
summary of findings
To the authors’ knowledge, this is the first in- depth enquiry 
specifically investigating how the UK public feel about their 
medical free text being shared outside the National Health 
Service (NHS) for research, and results can be used to inform 
national policy. The 18 citizens who participated were largely 
in favour of these data being shared for research using an opt- 
out model, although they did raise some concerns about patient 
privacy and gave some suggestions to mitigate these concerns.
Importantly, these results suggest that when fully informed, 
the public have similar views about their free text and coded 
data being shared for research. Jurors’ views were similar to 
those found by other citizens’ juries on sharing health data in 
general. For example, a UK study in which two juries were held 
in Manchester in 2016,34 to investigate public opinion towards 
the use of health data for research, found that 33 out of 34 were 
in favour of this, with the majority favouring an opt- out process. 
Other forms of qualitative research, such as Clerkin et al,48 have 
found that participants are overall positively inclined towards 
their patient records being used in research for the ‘greater 
good’, although participants expressed concerns about personal 
information being ‘leaked’. Participants in the focus groups in 
the study by Spencer et al49 were supportive of sharing their 
anonymised electronic patient record for research, and likewise, 
participants in the focus group in the study by Hill et al50 became 
more accepting of data sharing after being given information on 
selection bias and research processes. This suggests that a delib-
erative process, where participants are informed, does have the 
capacity to change participants’ views, and that the majority 
(though not all) become more positive about data sharing.
In our study, while showing general willingness to share, 
participants had several caveats about the use of medical free 
text for research. The key concerns were that patients are 
currently unlikely to be aware of the uses of their data beyond 
their immediate care because data uses are not transparent; that 
unauthorised third parties may be able to gain access to the data 
and that if patients feel like their medical confidentiality is being 
breached they are less likely to disclose important information 
to their doctor. These concerns largely map on to those found 
in other studies, for example, in the Manchester juries,34 partic-
ipants felt that without a clear understanding of who would be 
regulating the data and making decisions about access, it would 
be difficult to support the sharing of data for research, and 
participants were concerned that organisations without proper 
permission or legal authority may access the data.
As our study was the first to ask participants specifically about 
sharing medical text, it is the first to draw out and compare key 
concerns relating to text as opposed to structured data. Despite 
appreciating that free text could not be perfectly de- identified, 
the majority of jurors believed the benefits of sharing data for 
research outweighed the privacy risks. Jurors did explicitly state 
the need for a culture of continuous improvement in de- iden-
tification methods, which appears to be a novel suggestion not 
previously offered by other juries. The jury members were able 
to understand the distinction between text and structured data 
and specifically evaluate the associated benefits and privacy risks. 
They noted that free text could contain richer, or more accurate 
information which may enable better research that could lead to 
better treatments, improve care and save lives. However, they 
acknowledged that it could not be perfectly de- identified and 
that the risk to privacy by sharing text data was greater than for 
sharing coded data. Of particular interest, the jury recognised 
that free- text patient data could contain information that could 
be misinterpreted by researchers and felt that its use should be 
approached with caution.
Implications for health research and data policy
This informed group of citizens largely agreed that, with appro-
priate safeguards in place such as computerised de- identifica-
tion and access restricted to appropriate persons, the benefits 
of sharing medical text from patient records outweighed the 
risks to individual privacy. Medical free text is not usually 
shared outside the NHS clinical care environment at the current 
time, despite growing research capabilities to extract informa-
tion from it. These findings give the first evidence to policy 
makers about public opinion, which can be taken into account 
for making policy decisions about text sharing. Importantly, we 
provide evidence to policy makers that a well- informed public is 
likely to support sharing medical text data for research for the 
public good, with appropriate safeguards. These findings chal-
lenge existing data- sharing practices. However, the jury partici-
pants asked to give ‘suggestions’ for safeguards to mitigate their 
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Table 4 Views on de- identification of free- text data
How comfortable are you with de- identification of free- text 
patient data:
Participants’ response
Comfortable somewhat comfortable neither somewhat uncomfortable uncomfortable
I. Where done by a person (researcher or healthcare professional)? 5 11 0 2 0
II. Where done by a computer? 5 12 0 1 0
III. Where done by a combination of a person and a computer? 8 10 0 0 0
Table 5 Views on methods of processing free text
How supportive are you of each of the processes for extracting clinical information 
from free text, as described below?
Participants’ response
strongly 
supportive
Fairly 
supportive neither
Fairly 
unsupportive
strongly 
unsupportive
I. Where text is coded by the healthcare professional (eg, GP or nurse) who provides care and 
records the free text?
7 8 1 2 0
II. Where text is first anonymised by computer and/or person, then provided to a research 
team who will read the free text in order to gain a deep understanding of a specific thing 
(qualitative analysis)?
7 10 0 1 0
III. Where text is first anonymised by computer and/or person, then coded by a medical 
student and checked by a healthcare professional from the research team?
11 6 0 1 0
IV. Where text is first anonymised by computer and/or person, then coded by a medical 
student and checked by a healthcare professional, and then used to develop a computer 
program which would automatically code other patient records for research?
10 8 0 0 0
V. Where text is first anonymised by computer and/or person, then automatically coded by a 
computer program and checked by a healthcare professional?
7 10 1 0 0
concerns, rather than ‘conditions’ within which they would be 
willing to share. We cannot know, therefore, if their suggestions 
are conditions for implementation of data- sharing, or simply 
articulated guidance for a best- case scenario.
In the light of these findings, and the fact that data regula-
tions do not distinguish between free- text and structured data, 
it is interesting and arguably surprising that data providers are 
almost uniformly unwilling to allow researchers access to free 
text. Data providers are an informed group of decision makers 
who one might expect to have similar views to a citizens’ jury. 
However, free text is usually routinely redacted from datasets 
because it is seen as an unknown that might contain identifying 
data, with evidence that decisions are becoming more cautious 
in recent years (eg, the UK- based Clinical Practice Research 
Datalink (CPRD) used to provide free text to researchers but 
stopped this service in 2016; text is no longer held by CPRD or 
available to researchers51). This suggests that their motive for 
extreme caution, beyond what is practised for structured data, 
may be motivated by an anxiety about public perceptions, in the 
absence of evidence on likely public views, and by a currently 
unquantifiable risk to patients’ privacy of de- identified text data, 
in a climate where any kind of leak or breach could lead to loss 
of public trust and high financial penalty.
When and if national policy on sharing medical text is updated 
and reconsidered, it should respect the suggested mitigations 
proposed by this jury, which are well reasoned on the evidence 
that was presented to them. These mitigations include provision 
of patient- facing information to ensure complete transparency of 
data usage, such as posters clearly displayed in patient areas, or 
patient information leaflets provided on registration. This should 
explain a simple pathway for patients to opt out of having their 
de- identified free text shared. There should also be well- defined 
routes for patients who wish to get involved in decision- making 
bodies such as data providers and regulators, and information 
about patient representatives acting on behalf of patients as a 
group. Interestingly, the jury participants suggested healthcare 
text researchers should develop and make transparent a ‘culture 
of continuous improvement’ in technology for de- identification 
and information extraction of medical text, given that methods 
for de- identification and information extraction currently 
operate with certain levels of inaccuracy. These recommenda-
tions tie in with the theory of social licence, whereby honouring 
additional safeguards such as these, over and above any legal 
requirements, may help to engender trust and maintain transpar-
ency and secure societal approval for the research.
Future research directions
This is the first step in understanding how the public views the 
sharing of their medical text for research. Although the partic-
ipants in our study became well informed, nonetheless we are 
only able to show the view of 18 members of the public. We 
would need to scale up this research in the future to a wider pool 
of participants to be sure that these findings are not limited to 
particular attributes of the current jury.
Additionally, despite thorough communication throughout 
the jury of the majority of information needed to base their deci-
sions on, presenters were not always able to answer some of the 
jury’s questions. For example, it is not currently known how 
likely various risks to privacy are, such as the chance of re- iden-
tification from free text, because so little data have previously 
been shared, thus there is no open- source data on breaches as 
a result of data sharing. In the future, to reassure patients, it 
would be good for the text analysis community to develop esti-
mates of the likelihood of a patient being re- identified in various 
circumstances.
Public views are complex, and interpreting them to guide policy 
can be difficult. Some of us have previously argued that a concise 
ethical framework such as Beauchamp and Childress four princi-
ples,52 can act as a focusing lens, and that the public’s attitude to 
health data sharing can be interpreted through this lens.6 Respect 
for autonomy of individuals can be enacted through a meaningful 
and transparent opt- out policy, in line with national strategies 
for other sources of health data. Principles of justice should be 
written into any data- sharing agreements drawn up with research 
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Table 6 Perception of bias in the jury
Question
Participants’ response
not at all Perhaps occasionally sometimes often Very often
Did you ever feel that the jury facilitators tried to 
influence you towards particular conclusions?
18 0 0 0 0
Did you ever feel that anyone else (other than the 
other members of the jury) tried to influence you 
towards particular conclusions?
12 6 0 0 0
  Yes, overall it seemed a 
fair balance.
No, overall I thought there was some 
bias in favour of using free- text data 
for research.
No, overall I thought there 
was some bias in favour of 
protecting information
Do you feel that overall that the information you 
were given provided a fair balance of information 
about using free- text data for research and protecting 
information?
15 3 0
or commercial organisations outside the health service. Evidence 
that using free- text data for health research will result in the 
public good (beneficence) is currently sparse, and it is therefore 
imperative for the research community to bring together a body 
of evidence showing the potential benefits to patients of the use 
of their free- text data in research. The possibility of individual or 
collective harm (maleficence) should also be studied; potential 
harms from data sharing have been articulated by the public as 
identity theft, discrimination in employment, pension eligibility 
or insurance, stigmatising judgements in clinical settings or the 
community and the use of EHR data for financial profit- making.6 
The route to these harms is usually posited to be through re- iden-
tification of the individual from their de- identified data. It is not 
clear how easily patients can be re- identified from imperfectly 
de- identified text data which is nevertheless stored in an NHS or 
university data safe- haven, nor who would have the motivation 
to do this. Quantifying the risk of re- identification by a series of 
tests, perhaps on simulated patient documents, might be one way 
in which we can better inform patients, data custodians and regula-
tors about the true nature of privacy risks; this has been attempted 
on structured datasets.53 Increasing trustworthiness of research 
endeavours with patient data through transparency, and inclusivity 
of all stakeholders in the research process, remains paramount to 
ethical practice in this field.54
strengths and limitations
One of the strengths of this study is its use of a recognised delib-
erative method which has been replicated many times. In addi-
tion, the original developers of this method were involved in the 
design and delivery of this jury, in order to make sure all aspects 
of the technique were followed appropriately.
A criticism of citizens’ juries is the risk of bias being intro-
duced when the presentations are given. We included an inde-
pendent oversight committee in the development of materials to 
reduce (but not eliminate) bias, and this committee did request 
changes to several of the presenters’ materials. Despite this, 
some bias was perceived by participants. It may be difficult to 
avoid a perception of bias from the impartial witnesses, as we 
necessarily chose experts working in the field of text analytics, 
who are therefore more likely to be positive about the use of 
medical data for this purpose.
In addition, we asked members of the public to become skilled 
in evaluating and deliberating about difficult and complex mate-
rial in <3 days. This was a jury full of complexity and nuance, 
so it is possible that presentations missed out some important 
points that would have influenced decision- making, or there 
may have been misunderstandings among jury members. We 
tried to reduce this chance as much as possible by allowing every 
witness to be questioned by the jurors and by other witnesses in 
some cases. In addition, participants were allowed to question 
one witness after the jury had a day to discuss her presentation 
among themselves. Thus, we believe most jurors were given 
enough information to make an informed decision.
One potential criticism of our method of evaluating percep-
tion of bias at the end of the jury could be the wording of the 
question “Did you ever feel that anyone else (other than the other 
members of the jury) tried to influence you towards particular 
conclusions?”; this could have been worded explicitly to exclude 
the witnesses who made persuasive cases for and against the use 
of free- text data. The very positive responses to this, suggesting 
a lack of perceived bias, may suggest jurors were subject to social 
desirability bias in their response to these particular questions.
Further limitations are the very limited collection of quali-
tative data such as audio- recordings of the deliberations. This 
limited our ability to make sense of the jury’s conclusions, and 
also to understand the thought process which brought the jury 
members to their final decisions. We chose to compose our 
sample with the same distribution of views on data sharing as 
was found in the Ipsos MORI survey.35 It is possible that using 
this data- sharing question as part of the selection process could 
have introduced bias, as the population majority view is largely 
in favour of data sharing. Conversely, there remains the possi-
bility that views on data sharing in general would not directly 
predict the jury’s views on free- text data specifically, as we 
expected the jury members to have qualitatively different views 
on this format of data.
Finally, one of the limitations of this jury is that it did not 
address other related questions about health data sharing such as 
the use of medical text data by private or profit- making compa-
nies, the linkage of one set of patient records with another source 
of clinical or administrative data or sharing patient generated 
free text from social media. All the presentations were focused 
on public sector researchers such as those at universities, and on 
healthcare or clinic generated text. Thus, we cannot say how the 
public would feel about sharing different data with other types 
of research groups.
ConClusIons
An informed group of 18 citizens were largely in favour of 
sharing of medical free text research if patients were given full 
information and had the chance to opt out. They acknowledged 
the slight risk to patient privacy when medical text data were 
shared, and suggested that a transparent culture of research for 
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the public benefit, and commitment to continuous improvement 
of technology to protect patient privacy, would assuage their 
current concerns about free- text data sharing. These rich find-
ings can be taken forward to inform UK national policy around 
sharing NHS patient data for research.
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